Navigation Links
Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
Date:10/18/2007

tients during or shortly after completing treatment with PEGINTRON.

The following serious or clinically significant adverse events have been reported at a frequency less than 1% with PEGINTRON or interferon alpha: Severe decreases in neutrophil or platelet counts, hypothyroidism, hyperglycemia, hypotension, arrhythmia, ulcerative and hemorrhagic colitis, development or exacerbation of autoimmune disorders including thyroiditis, RA, systemic lupus erythematosus, psoriasis, pulmonary disorders (dyspnea, pulmonary infiltrates, pneumonitis and pneumonia, some resulting in patient deaths), urticaria, angioedema, bronchoconstriction, anaphylaxis, retinal hemorrhages, and cotton wool spots.

In the PEGINTRON/REBETOL combination trial, the incidence of serious adverse events was 17% in the PEGINTRON/REBETOL groups compared to 14% in the INTRON A/ REBETOL group. The incidence of severe adverse events in the PEGINTRON/REBETOL combination therapy trial was 23% in the INTRON A/REBETOL group and 31-34% in the PEGINTRON/REBETOL groups. Dose reductions due to adverse reactions occurred in 42% of patients receiving PEGINTRON (1.5 mcg/kg)/REBETOL and in 34% of those receiving INTRON A/REBETOL.

Additional Safety Information

Relapse of drug addiction/overdose has occurred in patients on PEGINTRON therapy. Aggressive behavior sometimes directed towards others has occurred in patients with and without a previous psychiatric disorder during PEGINTRON and/or INTRON A treatment and follow-up. If patients develop psychiatric problems, including clinical depression, it is recommended that patients be carefully monitored during treatment and in the 6-month follow-up period. If psychiatric symptoms persist or worsen, or suicidal ideation or aggressive behavior towards others is identified, it is recommended that treatment with PEGINTRON and/or INTRON A be discontinued, and the patient be carefully followed with psychiatric intervention, as appropriate. Cases of encephalo
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
2. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
5. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
6. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
7. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Sygnis Pharma AG announces date for presentation of clinical results
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... FORT COLLINS, Colo., Dec. 14 Manchester ... 250 mg (chenodiol tablets). On October 22, ... approved Chenodal, an important therapy for patients suffering ... health risk due to disease or advanced age. ... to patients exclusively through Centric Health Resources ("Centric"), ...
(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 Travelers of Interstate 70 ... has become a bit more colorful when 10 multicolored ... which is named going home , will eventually ... Armstrong, a graduate student at Herron School of Art ... and Public Life. ,, Eli Lilly and Company ...
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
Breaking Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco 60153 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 1Soligenix to Present at 8th Annual BIO Investor Forum 14615 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 3Soligenix to Present at 8th Annual BIO Investor Forum 14615 4
(Date:12/14/2009)... Dec. 14 Grubb & Ellis Healthcare REIT II, ... a daily distribution to stockholders of record as of the ... on Jan. 1, 2010 and ending on Feb. 28, 2010. ... in the calendar year and will be equal to an ... of $10.00 per share. These distributions will be aggregated ...
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... and shouldn,t worry most users, researcher says , , MONDAY, ... antidepressants may have a small but statistically significant increased ... on the medications, a new study finds. , "But ... Dr. Jordan W. Smoller, an associate professor of psychiatry ... report in the Dec. 14 issue of Archives ...
(Date:12/14/2009)... HILL -- Type 2 diabetes and obesity are linked ... published studies suggested that insulin glargine (a synthetic insulin ... associated with a higher risk of certain cancers than ... these studies were unable to control for important factors ... , On the other hand, a large randomized ...
(Date:12/14/2009)... perceived age to physical, mental functioning , , , MONDAY, ... than their age tend to live longer than those ... suggests. , The finding came from research that involved ... given physical and cognitive tests and then had their ... photos and indicated the age they perceived the participants ...
Breaking Medicine News(10 mins):Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Looking Younger Than Your Age May Mean Longer Life 2
... Inc. (NYSE: ARE ) today announced the Company ... Monday, February 9, 2009, at 3:00 p.m. Eastern Time (ET), ... results for the fourth quarter and year ended December 31, ... before the market opens on Monday, February 9, 2009. , ...
... 2 Walden University,s M.S. in ... Council for Accreditation,of Counseling and Related Educational Programs ... for Higher Education,Accreditation that accredits counselor preparation master,s ... education institution that offers a,CACREP-accredited M.S. degree in ...
... the formation of fibroblasts during development also promotes their ... et al. in the February 9, 2009 issue of ... conversion of epithelial cells into fibroblast-like mesenchymal cells is ... The transcription factor Snail1 induces this conversion (known as ...
... Pharmacy Retail Level, Kidz-Med Thermofocus 5-in-1 Debuts on "Fox ... Resources (Pink Sheets: ASFX) today announced that pharmacy retail ... of 2008 compared to the 4th quarter of 2007. ... the economic recession, since implementing particular offline and online ...
... Availity, LLC, a leading health,information network, today ... of medical and behavioral health management software, ... transactions. Health care,providers with MedEZ software can ... Information Network. The partnership provides MedEZ,customers with ...
... @Heart Campaign Encourages the 44 Million Women Living with or ... Heart Health -WASHINGTON, Feb. 2 Heart disease is the ... still not receiving the same in-hospital treatment that men do ... more likely to die.(ii) In an effort to address ...
Other Medicine News:Health News:Walden University's M.S. in Mental Health Counseling Program Receives CACREP Accreditation 2Health News:Walden University's M.S. in Mental Health Counseling Program Receives CACREP Accreditation 3Health News:Fibroblasts invade at a snail's pace 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 3Health News:Availity Partners With MedEZ 2Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 2Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 3Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 4Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: